Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | serine/threonine protein kinase | 0.0104 | 0.0227 | 0.0227 |
Brugia malayi | Protein kinase domain containing protein | 0.0104 | 0.0227 | 1 |
Schistosoma mansoni | sphingosine kinase A B | 0.1536 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.1536 | 1 | 1 |
Onchocerca volvulus | 0.0178 | 0.0733 | 0.5 | |
Echinococcus granulosus | dual specificity | 0.0104 | 0.0227 | 0.0227 |
Plasmodium vivax | serine/threonine kinase-1, putative | 0.0071 | 0 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0175 | 0.0712 | 0.972 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0175 | 0.0712 | 0.972 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0071 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0103 | 0.022 | 0.022 |
Leishmania major | serine/threonine-protein kinase, putative,protein kinase, putative | 0.0104 | 0.0227 | 0.3101 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0178 | 0.0733 | 0.0733 |
Echinococcus multilocularis | sphingosine kinase 1 | 0.1536 | 1 | 1 |
Entamoeba histolytica | hypothetical protein, conserved | 0.1536 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0175 | 0.0712 | 0.0712 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein | 0.0076 | 0.0037 | 0.0503 |
Giardia lamblia | Hypothetical protein | 0.0105 | 0.0235 | 1 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.0178 | 0.0733 | 0.0733 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0178 | 0.0733 | 1 |
Schistosoma mansoni | sphingoid long chain base kinase | 0.1536 | 1 | 1 |
Echinococcus granulosus | 6 phosphofructo 2 kinase:fructose 2 | 0.0178 | 0.0733 | 0.0733 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0076 | 0.0037 | 0.0503 |
Mycobacterium tuberculosis | Conserved protein | 0.1536 | 1 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0076 | 0.0037 | 0.0503 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0178 | 0.0733 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1536 | 1 | 1 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0105 | 0.0235 | 0.0008 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0175 | 0.0712 | 0.972 |
Toxoplasma gondii | cell-cycle-associated protein kinase CLK, putative | 0.0071 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0175 | 0.0712 | 0.972 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0178 | 0.0733 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0076 | 0.0037 | 0.0503 |
Echinococcus multilocularis | dual specificity | 0.0104 | 0.0227 | 0.0227 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.0215 | 0.0215 |
Trypanosoma cruzi | CMGC/DYRK protein kinase, putative | 0.0104 | 0.0227 | 0.3101 |
Giardia lamblia | Hypothetical protein | 0.0105 | 0.0235 | 1 |
Trypanosoma brucei | CMGC/DYRK protein kinase, putative | 0.0104 | 0.0227 | 0.3101 |
Plasmodium falciparum | protein serine/threonine kinase-1 | 0.0071 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0103 | 0.022 | 0.022 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0178 | 0.0733 | 1 |
Loa Loa (eye worm) | CMGC/DYRK/DYRK1 protein kinase | 0.0104 | 0.0227 | 0.0227 |
Trypanosoma cruzi | CMGC/DYRK protein kinase, putative | 0.0104 | 0.0227 | 0.3101 |
Loa Loa (eye worm) | hypothetical protein | 0.0178 | 0.0733 | 0.0733 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 1000 nM | In vitro inhibitory concentration on chloroquine resistant Plasmodium falciparum W2 strain | ChEMBL. | 14998331 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.